Proton prostate therapy may have unwanted side effects - abc7.com

abc7.com

Proton prostate therapy may have unwanted side effects abc7.com Proton therapy, a new prostate cancer treatment, may come with worse side effects than traditional radiation therapy. (KABC Photo) LOS ANGELES (KABC) -- A new prostate cancer treatment may come with worse side effects than traditional radiation therapy ... Study: Proton therapy may have more side effects than usual radiation for ...Washington Post Study questions proton therapy for prostate cancerFox News all 145 news articles »

Medivation prostate cancer drug well-tolerated in trial - Fox News

Medivation prostate cancer drug well-tolerated in trial Fox News Print Email Share Comments Recommend Tweet Medivation Inc's experimental prostate cancer pill caused fewer serious side effects in clinical trial patients than a placebo treatment, according to full results from a pivotal study announced on Tuesday. Medivation Surges on Prostate Cancer Drug: San Francisco MoverBusinessWeek Side Effect of Low Side Effects: 20% Stock GainDailyFinance Gaining on Prostate CancerWall Street Journal all 82 news articles »

Seed therapy for prostate cancer may zap fertility - Reuters

Seed therapy for prostate cancer may zap fertility Reuters By Amy Norton | NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds. The damage, researchers say, would seem to be enough to ... and more »

Effect of dietary polyunsaturated fatty acids on castration-resistant Pten ... - UroToday

Effect of dietary polyunsaturated fatty acids on castration-resistant Pten ... UroToday In the present study, we sought to determine whether dietary polyunsaturated fatty acid (PUFA) affects the development of castration-resistant prostate cancer. Cell culture, patient tissue microarray, allograft, xenograft, prostate-specific Pten ...

Why CEO Replacement Is Good News For Dendreon - Forbes

The Seattle Times

Why CEO Replacement Is Good News For Dendreon Forbes The news that Dendreon is under new management should cheer investors and help lay the groundwork for figuring out how to best sell the company's groundbreaking prostate cancer treatment, Provenge, which aims to harness the immune system to fight ... Dendreon And Provenge's True Median Life-Extension BenefitSeeking Alpha Dendreon Announces Presentation of PROVENGE Data at the ASCO 2012 ...MarketWatch (press release) all 72 news articles »